Harms to body and soul - An ideological balancing act for preventing and reducing cannabis use

Addiction

Volumn 105, Issue 8, 2010, Pages 1331-1332

  Solowij, Nadia ^a  

^a UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Cannabis; mental health; policy; schizophrenia

Indexed keywords

CANNABIS SMOKING; HUMAN; NOTE; SCHIZOPHRENIA; TOBACCO;

HUMANS; MARIJUANA SMOKING; SCHIZOPHRENIA; TOBACCO;

EID: 77954504975     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2010.02923.x     Document Type: Note

References (15)

1. Macleod J., Hickman M. How ideology shapes the evidence and the policy: what do we know about cannabis use and what should we do? Addiction 2010 105 : 1326 1330.
2. Murray R. M., Morrison P. D., Henquet C., Di Forti M. Cannabis, the mind and society: the hash realities. Nat Rev Neurosci 2007 8 : 885 895.
3. Solowij N., Michie P. T. Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia? J Psychiatry Neurosci 2007 32 : 30 52.
4. Henquet C., Di Forti M., Morrison P., Kuepper R., Murray R. M. Gene-environment interplay between cannabis and psychosis. Schizophr Bull 2008 34 : 1111 1121.
5. Luzi S., Morrison P. D., Powell J., Di Forti M., Murray R. M. What is the mechanism whereby cannabis use increases risk of psychosis? Neurotox Res 2008 14 : 105 112.
6. Yücel M., Solowij N., Respondek C., Whittle S., Fornito A., Pantelis C. et al. Regional brain abnormalities associated with long-term heavy cannabis use. Arch Gen Psychiatry 2008 65 : 694 701.
7. Bhattacharyya S., Fusar-Poli P., Borgwardt S., Martin-Santos R., Nosarti C., O'Carroll C. et al. Modulation of mediotemporal and ventrostriatal function in humans by delta 9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. Arch Gen Psychiatry 2009 66 : 442 451.
8. D'Souza D. C., Sewell R. A., Ranganathan M. Cannabis and psychosis/schizophrenia: human studies. Eur Arch Psychiatry Clin Neurosci 2009 259 : 413 431.
9. Fernandez-Espejo E., Viveros M. P., Nunez L., Ellenbroek B. A., de Fonseca F. R. Role of cannabis and endocannabinoids in the genesis of schizophrenia. Psychopharmacology 2009 206 : 531 549.
10. Rutten B. P. F., Mill J. Epigenetic mediation of environmental influences in major psychotic disorders. Schizophr Bull 2009 35 : 1045 1056.
11. Degenhardt L., Hall W. D., Lynskey M., McGrath J., McLaren J., Calabria B. et al. Should burden of disease estimates include cannabis use as a risk factor for psychosis? PLoS Med 2009 6 : e1000133. DOI:10.1371/journal.pmed. 1000133.
12. Copeland J., Swift W. Cannabis use disorder: epidemiology and management. Int Rev Psychiatry 2009 21 : 96 103.
13. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The State of the Drugs Problem in Europe: Annual Report 2009.
14. Kuntsche E., Simons-Morton B., Fotiou A., ter Bogt T., Kokkevi A. Decrease in adolescent cannabis use from 2002 to 2006 and links to evenings out with friends in 31 European and North American countries and regions. Arch Ped Adolesc Med 2009 163 : 119 125.
15. Degenhardt L., Chiu W. -T., Sampson N., Kessler R. C., Anthony J. C., Angermeyer M. et al. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med 2008 5 : e141. DOI:10.1371/journal.pmed.0050141.